与抗癌疗法相关的药物诱导的光敏感性
Davide Fattore1, Luca Potestio2, Ariadna Ortiz Brugués3
1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy - dott.davidefattore@gmail.com.
Italian journal of dermatology and venereology
|June 17, 2024
概括
抗癌治疗可以导致皮肤光敏感性,这是癌症护理中日益关注的问题. 提高意识有助于识别,预防和管理这些与太阳有关的不良药物反应.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗癌治疗虽然有效,但与各种皮肤学不良反应有关.
- 皮肤光敏感性,由阳光触发或恶化,是一个越来越公认的副作用.
研究的目的:
- 审查和报告与抗癌疗法相关的特征性光毒和光过敏反应.
- 识别其他潜在的与照相曝光相关的皮肤表现.
主要方法:
- 进行了全面的文献审查.
- 收集和分析了30份手稿.
主要成果:
- 该审查确定了与抗癌药物相关的几种光毒性和光过敏反应.
- 症状包括紫外线回忆,白风样反应,药物诱导的皮肤性红斑狼和紫外线诱导的超色素.
结论:
- 光敏反应在癌症管理中构成了重大挑战.
- 提高意识提高了对光敏感药物的识别,预防和管理.
- 需要进一步的研究,以更好地了解和个性化治疗策略皮肤毒性.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
192
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
192
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
222
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
222
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
257
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
257
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


